Catalog No.
Product Name
Application
Product Information
Citations
-
Antibiotic
Abbeymycin is an antibiotic derived from the actinobacterium Streptomyces sp. AB-999F-52, exhibiting potent antimicrobial activity primarily against anaerobic bacteria. Its specific action makes Abbeymycin a valuable tool in antibiotic discovery and screening research, aiding in the exploration of novel antimicrobial compounds. -
Antibiotic
Arylomycin B4 is a lipohexapeptide antibiotic specifically targeting Gram-positive bacteria. It demonstrates potent antimicrobial activity by inhibiting bacterial protein synthesis. This compound is valuable for research applications focused on the mechanisms of antibiotic resistance and the development of new antimicrobial agents. -
Antibiotic
Sapurimycin is an antitumor antibiotic derived from Streptomyces DO-116, belonging to the capramycin family. It demonstrates potent activity against Gram-positive bacteria and exhibits significant antitumor efficacy against leukemia P388 and sarcoma 180 in murine models. In vitro assays reveal that Sapurimycin induces single-strand breaks in supercoiled plasmid DNA, highlighting its potential utility in genomic studies and cancer research. -
Antibiotic
Cedarmycin A is an antibiotic with demonstrated efficacy against Candida species, Cryptococcus neoformans, and Aspergillus fumigatus, with minimum inhibitory concentration (MIC) values ranging from 12.5 to 50 μg/mL. It serves as a valuable research tool for investigating fungal infections and the development of antifungal therapies. Cedarmycin A's unique mechanism of action makes it an important compound for studying microbial resistance and host-pathogen interactions. -
Antitumor Antibiotic
Primocarcin is an antitumor antibiotic that specifically targets Ehrlich ascites carcinoma. Its mechanism of action involves the inhibition of tumor cell proliferation, making it a valuable compound for cancer research. Primocarcin is utilized in various studies aimed at understanding the efficacy of novel antitumor therapies and the biochemical pathways involved in cancer progression. -
Antibiotic
3''-Deamino-3''-hydroxykanamycin B is an antibiotic derived from the bacterium S. tenebrarius, specifically targeting bacterial ribosomes to inhibit protein synthesis. This compound exhibits notable effectiveness against Escherichia coli strains, including E. coli ATCC 25922 and E. coli CCARM 1A020, with minimum inhibitory concentration (MIC) values of 128 μg/mL. It is suitable for research applications involving antibiotic resistance and microbial susceptibility studies. -
Antibiotic
Eurocidin D is a cyclic peptide antibiotic that primarily targets and inhibits mast cell degranulation in rat models. This compound demonstrates significant anti-inflammatory properties, making it a valuable tool for studying allergic reactions and mast cell biology. Its unique mechanism of action positions it as a potential research candidate in understanding and treating conditions related to mast cell activation. -
Antibiotic
Lankacidinol is an antibiotic that exhibits significant biological activity against various pathogens. Its related metabolites, 2,18-seco-lankacidinol A and 2,18-seco-lankacidinol B, also demonstrate noteworthy medicinal properties. Notably, 2,18-seco-lankacidinol A has shown potent antitumor activity, making Lankacidinol a compound of interest for research in antibiotic and cancer therapeutics. -
Antibiotic
Oryzoxymycin is an aromatic derivative antibiotic targeting bacterial ribosomes to inhibit protein synthesis. This compound exhibits potent activity against Gram-negative bacteria, making it a valuable tool for studying antibiotic resistance mechanisms and bacterial infection pathways. It is applicable in research focused on microbial physiology and the development of new antibacterial agents. -
Antibiotic
BO-1165 is a potent antibiotic targeting Gram-negative bacteria with minimal efficacy against Gram-positive and anaerobic bacteria. It exhibits significant antibacterial activity against Pseudomonas aeruginosa, presenting a MIC50 of 3.12 mg/L, and against P. cepacia with a MIC50 of 1.56 mg/L. This compound is primarily utilized in research focused on combating infections caused by resistant Gram-negative pathogens. -
Antitumor Antibiotic
7-Hydroxyguanine is an antitumor antibiotic that primarily targets nucleic acid synthesis. It exhibits significant cytotoxicity against L1210 leukemia cells, effectively inhibiting their growth. This compound is utilized in cancer research to study mechanisms of action related to nucleobase analogs and their potential therapeutic applications. -
Antibiotic
Mikanolide is a sesquiterpene with notable antibacterial activity, primarily targeting Staphylococcus aureus. Demonstrating effective growth inhibition, it produces a zone of inhibition of 14 mm when tested at a concentration of 100 μg per disk. This compound may serve as a valuable tool in antibiotic research and the study of bacterial resistance mechanisms. -
Antibiotic
Dermadin is an antibiotic that targets bacterial infections through its antibacterial mechanisms. It exhibits significant antibacterial activity, making it suitable for research applications aimed at understanding and combating bacterial infections. This compound is particularly useful in studies focusing on antibiotic resistance and the development of new antimicrobial therapies. -
Antibiotic
Adenomycin is an antibiotic with a primary mechanism of action targeting mycobacteria. It demonstrates significant antimicrobial activity against a broad spectrum of mycobacterial species, making it a valuable reagent in research focused on mycobacterial infections and antibiotic resistance. Its efficacy in inhibiting mycobacterial growth facilitates studies in microbiology and drug development. -
Antitumor Antibiotic
16-Methyloxazolomycin is an antitumor antibiotic that exhibits significant antibacterial and antifungal activity. It has demonstrated efficacy against leukemia P388 cells and human lung adenocarcinoma cells, making it a valuable tool for cancer research and therapeutic development. This compound is utilized in the study of tumor biology and the exploration of novel therapeutic approaches in oncology. -
Antibiotic
Fluvirucin B1 is an antibiotic primarily targeting the influenza A virus. It exhibits potent antiviral activity by inhibiting viral replication, making it a valuable tool for research on influenza pathogenesis and antiviral drug development. Its efficacy in combating influenza A can aid in exploring therapeutic interventions in related viral infections. -
Antibiotic
Espinomycin A3 is a sixteen-membered macrolide antibiotic that targets bacterial protein synthesis, specifically inhibiting peptide elongation. It exhibits potent activity against Gram-positive bacteria, making it a valuable tool for research in antimicrobial mechanisms and antibiotic resistance. This compound is useful for studies focused on discovering new treatments for bacterial infections. -
Antitumor Antibiotic
13-Hydroxyglucopiericidin A is an antitumor antibiotic that exhibits potent cytotoxic activity against various cancer cell lines. Its mechanism involves inhibiting key cellular processes essential for tumor growth and proliferation. This compound is valuable for research in cancer biology and the development of novel therapeutic strategies targeting tumor cells. -
Antibiotic
3,6-Dihydroxyindoxazene is an antibiotic that demonstrates selective activity against Gram-negative bacteria. Isolated from Chromobacterium violaceum, it serves as a valuable tool in the study of bacterial resistance and antibiotic efficacy. Its unique mechanism of action provides insights into the development of new antimicrobial strategies and treatments. -
Antibiotic
Glycothiohexide α is a peptide antibiotic that targets bacterial cell wall synthesis. It exhibits potent activity against Gram-positive bacteria, including methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococcus (VREF), with minimum inhibitory concentration (MIC) values ranging from 0.03 to 0.06 μg/mL. This compound is valuable for research into antibiotic resistance and developing new therapeutic strategies against resistant infections. -
Bacterial Metabolite
Aklaviketone is a bacterial metabolite derived from the strain S 383 of Streptomyces galilaeus. This compound plays a crucial role in the biosynthetic pathway of anthracycline antibiotics, contributing to their formation and activity. Aklaviketone is valuable for research applications focused on antibiotic synthesis and microbial metabolism. -
Antibiotic
Lenapenem, a carbapenem antibiotic, exhibits potent antibacterial activity against both Gram-positive and Gram-negative bacteria, including Pseudomonas aeruginosa. This compound is utilized in research applications aimed at exploring bacterial resistance mechanisms and developing new antimicrobial strategies. Its efficacy against a broad spectrum of pathogens makes it a valuable tool for studying antibiotic pharmacodynamics and pharmacokinetics. -
Antibiotic
10'-Desmethoxystreptonigrin is an antibiotic that acts as an inhibitor of Ras Farnesyltransferase, exhibiting an IC50 of 21 μM. This compound demonstrates broad-spectrum antibacterial activity and shows antitumor effects against P388 leukemia, with an LD50 of 8.8 mg/kg indicating minimal cytotoxicity. It is a valuable reagent for research applications targeting antibiotic resistance and cancer therapeutics. -
Antibiotic
Acetylstachyflin is an antibiotic with demonstrated efficacy against Influenza A virus. Its primary mechanism involves targeting viral replication, thereby inhibiting the spread of the virus within host cells. This compound is valuable for research applications focused on antiviral drug development and understanding influenza pathogenesis. -
Antibiotic
Napyradiomycin B2 is an antibiotic that primarily targets Gram-positive bacteria and exhibits significant activity against mycobacteria. Its efficacy is limited against Gram-negative bacteria and fungi, making it a valuable compound for research into antimicrobial mechanisms and the development of new antibacterial agents. Napyradiomycin B2 is particularly relevant for studies investigating treatment options for infections caused by mycobacterial pathogens. -
Antibiotic
Saptomycin E is an antibiotic that exhibits antitumor properties by targeting and inhibiting bacterial protein synthesis. Its unique mechanism of action makes it a valuable tool for research in cancer biology and antibiotic development. This compound is effective in studying cell growth modulation and exploring therapeutic options against resistant bacterial strains. -
Antibiotic
Halomicin C is an ansamycin antibiotic that demonstrates antibacterial activity against both Gram-positive and Gram-negative bacteria. It serves as a valuable tool in microbiological research and the development of new antimicrobial agents, providing insights into bacterial resistance mechanisms and potential therapeutic applications. -
Antibiotic
Sannamycin G is an aminoglycoside antibiotic that exerts its activity primarily by inhibiting bacterial protein synthesis. While it demonstrates weak antibacterial activity against select bacterial strains, it serves as a valuable tool for research into antibiotic mechanisms and resistance. Its characterization can aid in the development of novel therapeutic strategies and the exploration of bacterial interactions. -
Antibiotic
Parvodicin C4 is a glycopeptide antibiotic that primarily targets bacterial cell wall synthesis. It demonstrates significant inhibitory activity against Staphylococcus aureus, Staphylococcus furfur, Staphylococcus hemolyticus, and Enterococcus faecalis. This compound is valuable for research applications focused on antibiotic resistance mechanisms and the development of new antimicrobial therapies. -
Antibiotic
11-Deoxy-13-dihydrodaunorubicin is an anthracycline antibiotic that primarily targets bacterial and tumor cells. It exhibits significant antibacterial activity against Gram-positive and negative bacteria, alongside notable antitumor properties. This compound is valuable for research applications in the fields of microbiology and oncology, particularly in the study of antibiotic resistance and cancer treatments. -
Antitumor Antibiotic
Miyakamide A2 is an antitumor antibiotic known for its insecticidal properties. It effectively inhibits the growth of Artemia salina and demonstrates moderate antixanthomonas activity. Additionally, Miyakamide A2 exhibits cytotoxic effects on P388 cancer cells, with an IC50 value of 12.2 μg/mL, making it applicable in cancer research and potential therapeutic development. -
Antibiotic
Deoxyfrenolicin is a quinone antibiotic that targets bacterial proliferation. Isolated from the fermentation broth of Streptomyces roseofulvus strain AM-3867, it belongs to the frenolicin class of antibiotics. Deoxyfrenolicin demonstrates significant antibacterial activity in vitro, effectively inhibiting the growth of Mycoplasma gallisepticum. This compound serves as a valuable tool for research applications in microbiology and antibiotic resistance studies. -
Antibiotic
Porothramycin B is an antibiotic that exhibits activity against Gram-positive and anaerobic bacteria. Its mechanism of action involves inhibiting bacterial protein synthesis, making it a valuable tool for studying bacterial infections. Researchers can utilize Porothramycin B in various microbiological applications, including the investigation of bacterial resistance mechanisms and the development of new therapeutic strategies. -
Antibiotic
Sakyomicin D is a benzoquinone antibiotic that primarily targets bacterial cell wall synthesis. It exhibits potent antibacterial activity against Gram-positive bacteria. This compound is utilized in research focused on combating antibiotic resistance and exploring novel antibacterial mechanisms. Its unique structure and mechanism of action make it a valuable tool for studying microbial pathogenesis and the development of new therapeutic agents. -
Antibiotic
Dapdiamide A is an antibiotic that targets bacterial cell viability, derived from the Pantoea agglomerans CU0119 strain. It demonstrates significant antibacterial activity, making it a valuable compound for anti-infective research applications. This compound may contribute to the development of novel therapeutic strategies against bacterial infections. -
Antibiotic
Epihygromycin is a glycoside antibiotic primarily targeting bacterial ribosomes. It exhibits modest activity against Gram-positive bacteria, making it valuable for studies on antibiotic resistance and microbial bioassays. Its mechanism of action facilitates investigations into bacterial protein synthesis and the efficacy of antibiotic treatments. -
Antibiotic
Pyridindolol K2 is an alkaloid antibiotic derived from Streptomyces species K93-0711. It exhibits the ability to inhibit the adhesion of HL-60 cells, making it a valuable tool for studying cell adhesion mechanisms and potential therapeutic applications. This compound is of interest in the development of novel antibacterial agents and in various cancer research applications. -
Antibiotic
Oxanosine is an antibiotic derived from the Streptomyces MG265-CF34 strain, exhibiting notable anti-tumor properties. This compound functions as a substrate for adenosine deaminase, highlighting its potential utility in various research applications related to microbial activity and cancer treatment. Its unique biochemical interactions make it a valuable reagent for studies in antibiotic development and tumor biology. -
Antibiotic
5-Hydroxy-4-oxo-L-norvaline is an antifungal antibiotic that inhibits protein biosynthesis in microbial cells. Its mechanism of action makes it a valuable tool in studying fungal growth and resistance. This compound is particularly useful for research applications focused on understanding antifungal mechanisms and the development of new therapeutic strategies against fungal infections. -
Antibiotic
Fluvirucin B2 is an antibiotic that specifically targets the influenza A virus. It exhibits antiviral activity by inhibiting viral replication, making it a valuable tool in researching antiviral therapeutic strategies. Fluvirucin B2 can be utilized in studies focused on understanding influenza pathogenesis and the development of effective antiviral agents. -
Antitumor Antibiotic
Reumycin is a 7-azapteridine antibiotic that functions as an antitumor agent. It exhibits cytotoxic activity against various tumor cell lines, including Airy carcinoma, sarcoma-180, sarcoma-37, and lymphosarcoma. This compound is primarily utilized in cancer research to study its effects on tumor proliferation and cell viability. -
Antibiotic
Pluracidomycin C2 is a carbapenem antibiotic that targets bacterial cell wall synthesis. It exhibits significant activity against both Gram-positive and Gram-negative bacteria, making it a valuable tool for studying antibiotic resistance and microbial pathogenicity. Its unique mechanism of action and broad-spectrum efficacy render it useful for various research applications in microbiology and pharmacology. -
Antibacterial Agent
Piperic acid is an antibacterial agent that exhibits natural antioxidant properties. It is recognized for its ability to inhibit bacterial growth, making it valuable for applications in food preservation and health-related research. Its utility in investigating antibacterial mechanisms further enhances its relevance in the study of microbial infections and therapeutic development. -
Antibiotic
Monamycin H2 is an ester peptide antibiotic that targets bacterial protein synthesis. It exhibits potent activity against Gram-positive bacteria, making it valuable in microbiological research. This compound is utilized to study antibiotic resistance and the mechanisms of bacterial growth inhibition. -
Antibiotic
Laidlomycin phenylcarbamate functions as a semisynthetic polyether antibiotic that exhibits notable antiparasitic activity. Its mechanism involves inhibiting protein synthesis, making it valuable for research into antimicrobial resistance and therapies involving parasitic infections. This compound is relevant in the study of antibiotic efficacy and the development of new treatments in infectious disease research. -
Antibiotic
Paldimycin B is a semi-synthetic antibiotic that exerts its activity primarily against Staphylococcus aureus and coagulase-negative staphylococci. It demonstrates significant antibacterial properties, making it valuable for research focused on bacterial infections and antibiotic resistance mechanisms. This compound serves as a useful tool for studying the efficacy and resistance profiles of various bacterial strains in the context of antimicrobial therapy. -
Antibiotic
Desacetylcephalothin sodium is a metabolite of the antibiotic Cephalothin, primarily targeting bacterial cell wall synthesis. Although it exhibits relatively weak antimicrobial activity compared to its parent compound, it serves as a valuable tool for studying antibiotic metabolism and resistance mechanisms. This reagent is useful in research applications related to the assessment of beta-lactam antibiotics and their derivatives. -
Antibiotic
BMS-180680 is a broad-spectrum antibiotic targeting gram-negative bacteria. It demonstrates potent antibacterial activity against Pseudomonas aeruginosa with a minimum inhibitory concentration (MIC) of 0.25 µg/ml. Additionally, BMS-180680 is resistant to hydrolysis by various β-lactamases, including TEM-2 and PSE enzymes, making it a valuable tool for research in antibiotic resistance and drug development. -
Antibiotic
Pneumocandin A4 is a lipopeptide antibiotic that targets the synthesis of 1,3-β-glucan, crucial for fungal cell wall integrity. It exhibits significant antifungal activity against Candida species, demonstrating an IC50 range of 0.07-0.5 μg/mL in vitro. This compound is valuable for research applications focused on antifungal mechanisms and the development of new therapeutic agents against fungal infections. -
Antibiotic
Arisostatin B is a tetrocarcin class antibiotic primarily targeting Gram-positive bacteria. It exhibits significant antibacterial properties, making it effective in combatting infections caused by resistant strains. Additionally, Arisostatin B demonstrates antitumor activity, supporting its potential applications in cancer research and therapy development.
